The type III TGF-β receptor suppresses breast cancer progressionMei Dong, Gerard C. Blobe|Journal of Clinical Investigation|2006Cited by 255
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3Rachel Hesler, Gerard C. Blobe|Carcinogenesis|2016Cited by 106
ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migrationBridgette N. Ray, Gerard C. Blobe|Carcinogenesis|2009Cited by 70
The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signalingJason D. Lee, Gerard C. Blobe|Carcinogenesis|2009Cited by 60
The type III transforming growth factor- receptor negatively regulates nuclear factor kappa B signaling through its interaction with -arrestin2Ho Jin You, Gerard C. Blobe|Carcinogenesis|2009Cited by 56